Dow Jones

38,589.16

-0.15%

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

VSAR

VERSARTIS, INC. (VSAR)

Aravive (delisted)

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:VSAR

1 2 3 4 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
19/10/2018	15:14	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:VSAR	Aravive (delisted)
17/10/2018	05:04	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:VSAR	Aravive (delisted)
16/10/2018	17:34	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VSAR	Aravive (delisted)
16/10/2018	17:07	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:VSAR	Aravive (delisted)
16/10/2018	16:07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VSAR	Aravive (delisted)
15/10/2018	06:00	GlobeNewswire Inc.	Aravive Biologics and Versartis Complete Merger	NASDAQ:VSAR	Aravive (delisted)
05/10/2018	15:47	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:VSAR	Aravive (delisted)
20/09/2018	16:05	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:VSAR	Aravive (delisted)
06/09/2018	15:22	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:VSAR	Aravive (delisted)
06/09/2018	08:27	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:VSAR	Aravive (delisted)
06/09/2018	05:01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:VSAR	Aravive (delisted)
04/09/2018	06:04	Edgar (US Regulatory)	Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)	NASDAQ:VSAR	Aravive (delisted)
08/08/2018	15:25	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:VSAR	Aravive (delisted)
08/08/2018	15:16	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:VSAR	Aravive (delisted)
07/08/2018	15:15	GlobeNewswire Inc.	Versartis Reports Second Quarter 2018 Financial Results and Reviews Recent Developments	NASDAQ:VSAR	Aravive (delisted)
03/08/2018	16:58	Edgar (US Regulatory)	Securities Registration: Business Combination (s-4)	NASDAQ:VSAR	Aravive (delisted)
24/07/2018	15:15	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:VSAR	Aravive (delisted)
10/07/2018	07:29	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:VSAR	Aravive (delisted)
04/06/2018	07:00	GlobeNewswire Inc.	Versartis Enters into Merger Agreement with Aravive Biologics to Form a Clinical-Stage Biopharmaceutical Company Advancing In...	NASDAQ:VSAR	Aravive (delisted)
08/05/2018	15:15	GlobeNewswire Inc.	Versartis Reports First Quarter 2018 Financial Results	NASDAQ:VSAR	Aravive (delisted)
11/04/2018	05:06	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:VSAR	Aravive (delisted)
26/03/2018	15:05	GlobeNewswire Inc.	Eyenovia Appoints Three Industry Veterans to Board of Directors	NASDAQ:VSAR	Aravive (delisted)
06/03/2018	16:29	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:VSAR	Aravive (delisted)
01/03/2018	15:05	GlobeNewswire Inc.	Versartis Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update	NASDAQ:VSAR	Aravive (delisted)
30/11/2017	07:00	GlobeNewswire Inc.	Report: Exploring Fundamental Drivers Behind Amerco, Caesars Entertainment, Air Products and Chemicals, Consolidated Edison, ...	NASDAQ:VSAR	Aravive (delisted)
26/10/2017	15:05	GlobeNewswire Inc.	Versartis Reports Third Quarter 2017 Financial Results and Provides Corporate Update	NASDAQ:VSAR	Aravive (delisted)
26/10/2017	15:05	GlobeNewswire Inc.	Versartis Hires Cowen to Assist in Evaluating Potential Strategic Transactions	NASDAQ:VSAR	Aravive (delisted)
21/09/2017	15:30	GlobeNewswire Inc.	Versartis Announces Phase 3 VELOCITY Trial of Somavaratan in Pediatric Growth Hormone Deficiency Did Not Meet Primary Endpoin...	NASDAQ:VSAR	Aravive (delisted)
07/09/2017	15:05	GlobeNewswire Inc.	Versartis’ Twice-Monthly Somavaratan for Pediatric Growth Hormone Deficiency to be Featured in Oral and Poster Presentation...	NASDAQ:VSAR	Aravive (delisted)
05/09/2017	15:05	GlobeNewswire Inc.	Versartis Announces Expansion of Executive Leadership Team with Addition of Dr. Robert Gut as the Head of Global Clinical, M...	NASDAQ:VSAR	Aravive (delisted)